DOCO

DOCO is a company dedicated to developing innovative laboratory solutions that enhance research capabilities across multiple industries, including pharmaceuticals and environmental testing. Founded in 2018 by Natalia Sokoloff and Valentina Rios, DOCO is headquartered in Shanghai, China. The company specializes in advanced laboratory equipment and analytical tools to support research and development processes. As of May 11, 2020, DOCO raised an undisclosed amount in strategic investment, solidifying its position in the market.

The company has completed a total of 3 deals since its inception. DOCO specializes in providing innovative solutions that cater to a diverse range of industries. Their main product offerings include advanced laboratory equipment and analytical tools designed to enhance research and development processes. These products function by enabling precise measurements and analyses, which are crucial for sectors such as pharmaceuticals, biotechnology, and environmental testing.

DOCO’s solutions aim to solve critical challenges in efficiency and accuracy, ultimately supporting scientists and researchers in their quest for reliable data. The company serves a global client base, with particular emphasis on markets in North America, Europe, and Asia, ensuring that their offerings meet the varied needs of customers across these regions. DOCO generates revenue through a structured transaction model that primarily encompasses B2B sales to laboratories and research institutions. Their flagship products are typically sold under a direct-to-consumer approach, allowing clients to purchase the equipment and tools necessary for their operations.

Pricing plans are established based on the specific product line, with options for bulk purchasing that cater to large institutional clients. In addition to one-time sales, DOCO may also engage in partnerships that facilitate ongoing support and maintenance services for their products, further solidifying their relationships with clients. Through these various transactional structures, DOCO ensures a steady flow of revenue while providing essential tools to its end-users. DOCO is focused on launching several new products designed to meet emerging research needs, though specific release dates have yet to be announced.

The company aims to expand its presence in North America and Europe by the end of 2022, targeting key markets where demand for laboratory solutions is growing. The strategic investment raised in May 2020 will be utilized to support these initiatives, enhancing product development and market penetration.